Esfahani, Shadi A.
de Aguiar Ferreira, Carolina
Rotile, Nicholas J.
Ataeinia, Bahar
Krishna, Shriya
Catalano, Onofrio A.
Caravan, Peter
Yen, Yi-Fen
Heidari, Pedram
Mahmood, Umar
Funding for this research was provided by:
RSNA Research and Education Foundation (Research Resident Grant)
Massachusetts General Hospital (Ralph Schlaeger Research Fellowship Grant)
NIH (R01CA211223, NCI K08CA249047-01, 5R25CA174650)
NIH (S10-OD023503)
Article History
Received: 24 April 2022
Revised: 7 July 2022
Accepted: 29 July 2022
First Online: 12 August 2022
Declarations
:
: U.M. is a cofounder and consultant of CytoSite Biopharma, a company focused on development of PET probes for immuno-oncology and has received support (materials) from Daiichi Sankyo related to HER3, but not used in the current study. All other authors do not have relevant conflicts of interest.